Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Emicizumab for the Treatment of Acquired Hemophilia a: A Multicenter US Case Series

Jacqueline N. Poston, Kadhim Al-Banaa, Annette von Drygalski, Aric D. Parnes, Christopher E Walsh, James F Wu, Craig M. Kessler, Maissaa Janbain, Lynn M Malec, Rebecca Kruse-Jarres

Blood (2021) 138 (Supplement 1): 496.

https://doi.org/10.1182/blood-2021-148040

Published: 2021

Journal Articles

Assessment of TRM-201 (Rofecoxib) Efficacy and Safety for Chronic Pain in Hemophilic Arthropathy: The Rofecoxib Efficacy and Safety Evaluation Trial in Hemophilic Arthropathy (RESET-HA), a Randomized, Double-Blind Placebo-Controlled Phase III Clinical Trial

Judith A. Boice, Tyler W. Buckner, Stacy E. Croteau, Nathaniel Katz, Robert F. Sidonio, Jr., Kim Mauer, James Bolognese, Mary Garfield, Mark Corrigon, Christopher E Walsh

Blood (2021) 138 (Supplement 1): 4243.

https://doi.org/10.1182/blood-2021-154056

Published: 2021

Journal Articles

BAX 335 hemophilia B gene therapy clinical trial results: potential impact of CpG sequences on gene expression

Barbara A. Konkle, Christopher E. Walsh, Miguel A. Escobar, Neil C. Josephson, Guy Young, Annette von Drygalski, Scott W. J. McPhee, R. Jude Samulski, Ivan Bilic, Maurus de la Rosa, Birgit M. Reipert, Hanspeter Rottensteiner, Friedrich Scheiflinger, John C. Chapin, Bruce Ewenstein, Paul E. Monahan

Blood (2021) 137 (6): 763–774.

https://doi.org/10.1182/blood.2019004625

Published: 2021

Includes: Supplemental data

Journal Articles

Impact of Mild to Severe Hemophilia B on Quality of Life Including Pain and Functional Abilities in Affected Men/Women and Caregivers of Affected Boys/Girls: Analysis of Patient Reported Outcomes in the Bridging Hemophilia B Experiences Results and Opportunities into Solutions (B-HERO-S) Study

Tyler W. Buckner, MD MSc, Michelle Witkop, DNP, FNP-BC, Christine Guelcher, PPCNP, Robert F. Sidonio, Jr., MD, Christopher E. Walsh, MD PhD, Craig M. Kessler, MD, David Clark, PhD, Wendy E. Owens, MA, Neil Frick, MS, Neeraj N Iyer, PhD, David L Cooper, MD MBA

Blood (2016) 128 (22): 251.

https://doi.org/10.1182/blood.V128.22.251.251

Published: 2016

Journal Articles

Recombinant long-acting glycoPEGylated factor IX in hemophilia B: a multinational randomized phase 3 trial

Peter W. Collins, Guy Young, Karin Knobe, Faraizah Abdul Karim, Pantep Angchaisuksiri, Claus Banner, Türkiz Gürsel, Johnny Mahlangu, Tadashi Matsushita, Eveline P. Mauser-Bunschoten, Johannes Oldenburg, Christopher E. Walsh, Claude Negrier

Blood (2014) 124 (26): 3880–3886.

https://doi.org/10.1182/blood-2014-05-573055

Published: 2014

Includes: Supplemental data

Journal Articles

Determination of Anti-Factor VIIII Antibody Titers, Isotypes and Epitopes by SPR Analysis of Human Plasma

Kenneth B Lewis, Ph.D., Phuong-Cac Nguyen, Ph.D., Jason T. Schuman, Ph.D., Christopher E. Walsh, MD, PhD, Neil C. Josephson, MD, Tom E. Howard, MD, PhD, Dana C. Matthews, MD, Nigel S. Key, MBChB, Kathleen P. Pratt, Ph.D.

Blood (2011) 118 (21): 202.

https://doi.org/10.1182/blood.V118.21.202.202

Published: 2011

Journal Articles

Factor IX ectopically expressed in platelets can be stored in α-granules and corrects the phenotype of hemophilia B mice

Guowei Zhang, Qizhen Shi, Scot A. Fahs, Erin L. Kuether, Christopher E. Walsh, Robert R. Montgomery

Blood (2010) 116 (8): 1235–1243.

https://doi.org/10.1182/blood-2009-11-255612

Published: 2010

Includes: Supplemental data

Journal Articles

Ectopic Expression of Human FIX in Mouse Platelets Can Store Releasable FIX in Platelets and May Be a Potential Strategy for Gene Therapy of Hemophilia B.

Guowei Zhang, Qizhen Shi, Scot A. Fahs, Christopher E. Walsh, Robert R. Montgomery

Blood (2007) 110 (11): 196.

https://doi.org/10.1182/blood.V110.11.196.196

Published: 2007

Journal Articles

Knockdown of the Fanconi Anemia Gene FANCD2 Directly Affects Hematopoiesis in Human Embryonic Stem Cells.

Beiqing Pan, Marion Kennedy, Gordon Keller, Vesna Najfeld, Christopher E. Walsh

Blood (2006) 108 (11): 1318.

https://doi.org/10.1182/blood.V108.11.1318.1318

Published: 2006

Journal Articles

Repair of von Willebrand Factor (vWF) Gene Defect by Targeted RNA Trans-Splicing.

Yanping Yang, Christopher E. Walsh

Blood (2006) 108 (11): 3277.

https://doi.org/10.1182/blood.V108.11.3277.3277

Published: 2006

Journal Articles

Human Factor IX Expression and Hemophilia Phenotypic Correction in Mice: A Comparison of AAV Serotypes.

Hengjun Chao, MD, Wei Chen, MD, James R. Tunstead, PhD, Christopher E. Walsh, MD, PhD

Blood (2004) 104 (11): 3985.

https://doi.org/10.1182/blood.V104.11.3985.3985

Published: 2004

Journal Articles

Induction of tolerance to human factor VIII in mice

Hengjun Chao, Christopher E. Walsh

Blood (2001) 97 (10): 3311–3312.

https://doi.org/10.1182/blood.V97.10.3311

Published: 2001

Journal Articles

Sustained expression of human factor VIII in mice using a parvovirus-based vector

Hengjun Chao, Lan Mao, Andrew T. Bruce, Christopher E. Walsh

Blood (2000) 95 (5): 1594–1599.

https://doi.org/10.1182/blood.V95.5.1594.005k34_1594_1599

Published: 2000

Journal Articles

Phenotypic correction of Fanconi anemia group C knockout mice

Kimberly A. Gush, Kai-Ling Fu, Markus Grompe, Christopher E. Walsh

Blood (2000) 95 (2): 700–704.

https://doi.org/10.1182/blood.V95.2.700

Published: 2000

Journal Articles

Functional Correction of Fanconi Anemia Group A Hematopoietic Cells by Retroviral Gene Transfer

Kai-Ling Fu, Jerome R. Lo Ten Foe, Hans Joenje, Kathleen W. Rao, Johnson M. Liu, Christopher E. Walsh

Blood (1997) 90 (9): 3296–3303.

https://doi.org/10.1182/blood.V90.9.3296

Published: 1997

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Emicizumab for the Treatment of Acquired Hemophilia a: A Multicenter US Case Series

Assessment of TRM-201 (Rofecoxib) Efficacy and Safety for Chronic Pain in Hemophilic Arthropathy: The Rofecoxib Efficacy and Safety Evaluation Trial in Hemophilic Arthropathy (RESET-HA), a Randomized, Double-Blind Placebo-Controlled Phase III Clinical Trial

BAX 335 hemophilia B gene therapy clinical trial results: potential impact of CpG sequences on gene expression

Impact of Mild to Severe Hemophilia B on Quality of Life Including Pain and Functional Abilities in Affected Men/Women and Caregivers of Affected Boys/Girls: Analysis of Patient Reported Outcomes in the Bridging Hemophilia B Experiences Results and Opportunities into Solutions (B-HERO-S) Study

Recombinant long-acting glycoPEGylated factor IX in hemophilia B: a multinational randomized phase 3 trial

Determination of Anti-Factor VIIII Antibody Titers, Isotypes and Epitopes by SPR Analysis of Human Plasma

Factor IX ectopically expressed in platelets can be stored in α-granules and corrects the phenotype of hemophilia B mice

Ectopic Expression of Human FIX in Mouse Platelets Can Store Releasable FIX in Platelets and May Be a Potential Strategy for Gene Therapy of Hemophilia B.

Knockdown of the Fanconi Anemia Gene FANCD2 Directly Affects Hematopoiesis in Human Embryonic Stem Cells.

Repair of von Willebrand Factor (vWF) Gene Defect by Targeted RNA Trans-Splicing.

Human Factor IX Expression and Hemophilia Phenotypic Correction in Mice: A Comparison of AAV Serotypes.

Induction of tolerance to human factor VIII in mice

Sustained expression of human factor VIII in mice using a parvovirus-based vector

Phenotypic correction of Fanconi anemia group C knockout mice

Functional Correction of Fanconi Anemia Group A Hematopoietic Cells by Retroviral Gene Transfer

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only